(NASDAQ: IFRX) Inflarx Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.39%.
Inflarx Nv's earnings in 2025 is -$52,664,795.On average, 4 Wall Street analysts forecast IFRX's earnings for 2025 to be -$49,455,405, with the lowest IFRX earnings forecast at -$65,037,245, and the highest IFRX earnings forecast at -$38,615,864. On average, 4 Wall Street analysts forecast IFRX's earnings for 2026 to be -$43,019,428, with the lowest IFRX earnings forecast at -$62,327,360, and the highest IFRX earnings forecast at -$27,098,852.
In 2027, IFRX is forecast to generate -$44,489,540 in earnings, with the lowest earnings forecast at -$67,747,130 and the highest earnings forecast at -$18,291,725.